P21 Adamantane

Compound Overview

P21 Adamantane is identified in the supplied research data as the adamantane-modified P021-style molecule used in neurotrophic pathway research models. The defining structural point is the adamantane-containing residue in the displayed structure, combined with the acetylated N-terminus and C-terminal amide described by the source record.

The compound should be understood as a research material with a specific identity profile rather than as a general P21 label. The provided warning notes that non-adamantane substitutions are common in vendor confusion around this product class. For that reason, the adamantane residue and cap state are not minor naming details; they are part of the technical identity that should be confirmed against supplier documentation, mass data, and available COA records before laboratory use.

Nexus lists this item as a 10mg research-size product under SKU PP10. No human-use, veterinary-use, therapeutic, diagnostic, disease-treatment, or dosing application is described or implied by this product page.

Research Background & Published Literature

The research background supplied for P21 Adamantane is concise. It identifies the compound as an adamantane-modified P021-style molecule and states that it is used in neurotrophic pathway research models. It also highlights the need to verify the adamantane moiety carefully because naming confusion around this product class can result in non-adamantane substitutions being treated as equivalent when they are not the same compound.

The structured source record does not provide article-level peer-reviewed citations for specific experimental outcomes. Because of that, this description does not add mechanism claims, efficacy language, model-specific results, disease context, or translational interpretation beyond the source text. Research teams evaluating P21 Adamantane should rely on their own literature review and on lot-specific analytical documentation for experimental planning.

The provided source list includes the following chemistry-oriented references:

These references are included only because they were present in the supplied research data. They should not be treated as a substitute for current batch-level verification, HPLC/MS review, or independent protocol design.

Researchers reviewing the literature around this compound can use the peer-reviewed resources below for additional context on mechanism of action, signaling pathways, and controlled laboratory research applications:

• Bolognin et al. (2014) — Neurobiol Aging
• Kazim et al. (2014) — Neurobiol Dis
• Baazaoui et al. (2017) — Alzheimers Res Ther

Storage, Handling & Stability Guidelines

The supplied storage instruction is to store lyophilized P21 Adamantane at -20°C, desiccated, and protected from light. After reconstitution, the source record advises aliquoting the material and avoiding repeated freeze-thaw cycles.

• Store sealed lyophilized material at -20°C.
• Keep material desiccated and protected from light during storage.
• After reconstitution, aliquot material where compatible with the validated laboratory workflow.
• Avoid repeated freeze-thaw cycles after reconstitution.
• Use appropriate PPE, labeling, and institutional chemical-safety controls for research reagents.
• Maintain traceability between the received vial, internal inventory record, and any available lot documentation.

No validated reconstitution solvent, concentration, post-reconstitution expiration interval, or stability-study dataset was provided in the source record. Those values should be determined only through laboratory SOPs, current supplier documentation, or lot-specific analytical records, not assumed from this description.

Lab Verification

Nexus maintains research-compound verification information through the Lab Verified archive. For P21 Adamantane, the current product record does not provide exact COA values, purity values, batch numbers, HPLC retention data, or mass-spectrum values, so this page does not present a compound-specific COA panel.

In general terms, researchers should confirm P21 Adamantane identity and quality using current lot documentation that includes HPLC purity review and Mass Spectrometry identity confirmation where available. For this compound specifically, the source warning emphasizes verification of the adamantane residue and cap state by supplier COA/MS because non-adamantane substitutions can be confused with this product class.

Before using material in a controlled in-vitro workflow, review the current record at /lab-verified and reconcile the product name, SKU, displayed sequence, CAS number, molecular weight, and formula against the received vial documentation.